% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, AŞ Message Board

  • kyjellie kyjellie Oct 19, 2012 7:59 AM Flag


    I spent some time reviewing guidance on expenses and ASTX stated expenses would be in the neighborhood of 88M for 2012. They expensed about $40M for the the first half of a year. With several drugs in phase 2, expenses will have increased. Maybe as much as $4M per quarter. We could see a loss in the vincinity of $5M for the quarter.

    My estimates:

    Revenues of 18M

    Expenses of 23M

    Loss of $5M

    How they treat the gain on SRPT stock could paint a better picture. The thing Dr. M always seems to pull off, is to grow ASTX cash position.

    Sentiment: Buy